A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.

Inclusion Criteria: * A Healthy male aged 19-50 years * Body weight is over 55kg and BMI 18 \~ 27(kg/m2). * A subject provide written informed consent which he voluntarily confirms willingness to participate in a study, having been informed of the full details of the study and comply with the protocol. * A subject who is eligible according to investigator's assessment Exclusion Criteria: * History or presence of clinically significant medical or psychiatric condition or disease. * History of gastrointestinal disease and resection * Hypersensitivity to ingredient of investigational product(IP) and other medication, food. * Genetic Problem such as Galactose intolerance, Lapp lactase deficiency or Glucose-galactose malabsorption. * A subject who take a drug that inhibit or induce significantly Drug-Metabolizing Enzyme within 1months. * Positive results for serum examination(HIV, B and C viral test, Syphilis). * Seated BP is less than 100/65 mmHg or greater than 140/90 mmHg at screening. * Participation in any other study within 3months. * History of whole blood donation within 2months and Apheresis 2 weeks.